Recent

% | $
Quotes you view appear here for quick access.

Dendreon Anonim Ortaklik Message Board

  • wchuck41 wchuck41 Jun 24, 2013 11:49 AM Flag

    break even coming in US and a buy in partner for the Eu:

     

    means cash in the bank and back to new highs.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ◦ Presented data at AUA that further analyzed Phase III IMPACT data to identify prognostic variables that may support early administration of PROVENGE after diagnosis of metastatic castrate resistant prostate cancer
      ◦ Actively evaluating partnering strategies for European expansion; continuing to enroll patients in the sipuleucel-T European Union open-label study; expect a regulatory decision in Europe in the second half of 2013
      ◦ Completed enrollment of PROVENGE and ADT sequencing study; presented initial data at ASCO-GU and expect to present additional data in 2013
      ◦ Completed enrollment of PROVENGE and Zytiga®(abiraterone) sequencing study; presented initial data at ASCO-GU and expect to present additional data in 2013
      ◦ Supporting 19 novel investigator initiated trials (IITs) to advance understanding of immunotherapy and the treatment of advanced prostate cancer
      ◦ Named steering committee for Phase II trial for sequencing PROVENGE with Xtandi® (enzalutamide) and expect to begin enrolling patients in the fourth quarter of 2013